Patents by Inventor Henry Fliss

Henry Fliss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIRAL VACCINE AND METHOD FOR PREPARATION THEREOF
    Publication number: 20080317780
    Abstract: The invention relates to a viral vaccine, especially a retroviral vaccine, and methods of forming such a vaccine. The vaccine is formed from a whole-killed virus suspension in a cell lysate or culture medium, wherein the virus is killed by exposure to a chloramine compound at a level adequate to inactivate zinc finger proteins. The chloramine compound may be taurine chloramine, adenosine chloramine, phenylalanine chloramine, and alanine chloramine. The vaccine may be used as a prophylactic or therapeutic vaccine and may be developed from a subject's own strains of virus so as to be considered an autologous vaccine.
    Type: Application
    Filed: October 26, 2007
    Publication date: December 25, 2008
    Applicant: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Henry FLISS, Anil DUDANI
  • Zinc ionophores as therapeutic agents
    Publication number: 20040167114
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Application
    Filed: January 16, 2004
    Publication date: August 26, 2004
    Inventor: Henry Fliss
  • Zinc ionophores as therapeutic agents
    Patent number: 6689774
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: February 10, 2004
    Assignee: Zinc Therapeutics, Canada Inc.
    Inventor: Henry Fliss
  • Zinc ionophores as therapeutic agents
    Publication number: 20030119805
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Application
    Filed: July 26, 2002
    Publication date: June 26, 2003
    Inventor: Henry Fliss
  • Zinc ionophores as therapeutic agents
    Patent number: 6495538
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: December 17, 2002
    Assignee: Zinc Therapeutics, Canada Inc.
    Inventor: Henry Fliss
  • Zinc ionophores as anti-stress agents
    Publication number: 20020183300
    Abstract: The present invention provides methods comprising one or more zinc ionophores for treating or reversing the effects of stress, including surgical stress in patients in need thereof.
    Type: Application
    Filed: April 4, 2002
    Publication date: December 5, 2002
    Inventor: Henry Fliss
  • Zinc ionophores as anti-apoptotic agents
    Patent number: 6407090
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for blocking apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: June 18, 2002
    Assignee: Zinc Therapeutics Canada, Inc.
    Inventor: Henry Fliss
  • Zinc ionophores as therapeutic agents
    Publication number: 20010036939
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Application
    Filed: January 12, 2001
    Publication date: November 1, 2001
    Inventor: Henry Fliss